Kidney function after 1:1 conversion to the cyclosporine microemulsion formulation in children with liver allografts

Transplantation

Volumn 63, Issue 12, 1997, Pages 1768-1772

  Laine, Jarmo ^a   Hoppu, Kalle ^a   Jalanko, Hannu ^a   Rönnholm, Kai ^a   Holmberg, Christer ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; CREATININE; CYCLOSPORIN; EDETATE CHROMIUM CR 51; GAMMA GLUTAMYLTRANSFERASE; LIVER ENZYME; METHYLPREDNISOLONE; POTASSIUM; PREALBUMIN; URATE;

ADOLESCENT; ALLOGRAFT; AREA UNDER THE CURVE; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG FORMULATION; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY; KIDNEY FUNCTION; LIVER TRANSPLANTATION; MALE; MICROEMULSION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STEADY STATE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DRUG DELIVERY SYSTEMS; EMULSIONS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; KIDNEY; KIDNEY FUNCTION TESTS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; PROSPECTIVE STUDIES;

EID: 0030925787     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199706270-00011     Document Type: Article

References (14)

1. Belle SH, Beringer KC, Murphy JB, Detre KM. The Pitt-UNOS liver transplant registry. In: Terasaki PI, Cecka LM, eds. Clinical transplants 1992. Los Angeles: UCLA Tissue Typing Laboratory, 1993: 17.
2. Kahan B, Dunn J, Fitts C, et al. Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals. Transplantation 1995; 59: 505.
3. Freeman D, Grant D, Levy G, et al. Pharmacokinetics of a new oral formulation of cyclosporine in liver transplant recipients. Ther Drug Monit 1995; 17: 213.
4. Mueller E, Kovarik J, van Bree J, Tetzloff W, Gravel J, Kutz K. Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation. Pharm Res 1994; 11: 301.
5. Hoppu K, Koskimies O, Holmberg C, Hirvisalo E. Pharmacokinetically determined cyclosporine dosage in young children. Pediatr Nephrol 1991; 5: 1.
6. Gibaldi M. Biopharmaceutics and clinical pharmacokinetics, 3rd ed. Philadelphia: Lea & Febiger, 1984.
7. Hoppu K, Jalanko H, Laine J, Holmberg C. Comparison of conventional oral cyclosporine to cyclosporine microemulsion formulation in children with a liver transplant: a pharmacokinetic and clinical study. Transplantation 1996; 62: 66.
8. Oellerich M, Raude E, Burdelski M, et al. Monoethylglycinexylidide formation kinetics: a novel approach to assessment of liver function. J Clin Chem Clin Biochem 1987; 25: 845.
9. Grevel J. Absorption of cyclosporine A after oral dosing. Transplant Proc 1986; 18 (suppl 5): 9.
10. Kovarik J, Mueller E, Van Bree J, et al. Cyclosporine pharmacokinetics and variability from a microemulsion formulation: a multicenter investigation in kidney transplant recipients. Transplantation 1994; 58: 658.
11. Holt D, Mueller E, Kovarik J, Van Bree J, Kutz K. The pharmacokinetics of Sandimmun Neoral: a new oral formulation of cyclosporine. Transplant Proc 1994; 26(5): 2935.
12. Bökenkamp A, Offner G, Hoyer P, Vester U, Wonigeit K, Brodehl J. Improved absorption of cyclosporin A from a new microemulsion formulation: implications for dosage and monitoring. Pediatr Nephrol 1995; 9: 196.
13. Levy G, Rochon J, Freeman D, et al. Cyclosporine Neoral in liver transplant recipients. Transplant Proc 1994; 26(5): 2949.
14. Laine J, Krogerus L, Fyhrquist F, Jalanko H, Rönnholm K, Holmberg C. Renal function and histopathology after liver transplantation in children. J Pediatr 1994; 125: 863.